Clinical Trials on Unilateral Breast Neoplasms in China

Total 16148 results

Shu lian Wang

Recruiting

Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer

Breast Cancer | Cardiac Event

China
Shu lian Wang

Completed

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer

Breast Neoplasms | Radiation Toxicity | Heart Injuries

China
Zhejiang Cancer Hospital

Unknown

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Breast Cancer | Breast Diseases | Neoplasm, Breast

China
Shanghai Jiao Tong University School of Medicine

Terminated

Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC (DETECT)

Breast Neoplasm

China
Organisation for Oncology and Translational Research

Unknown

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou Anjie Biomedical Technology Co., Ltd.

Completed

PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer

Advanced Breast Cancer | Breast Neoplasm Malignant Female

China
Chinese PLA General Hospital

Unknown

Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions

Neoplasm of Breast

China
Fudan University
Chongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaborators

Recruiting

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Breast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor

China
Shandong Cancer Hospital and Institute

Unknown

The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients

Breast Neoplasm

China
Chinese PLA General Hospital

Recruiting

Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation

Unilateral Deafness

China
Peng Yuan

Completed

Anlotinib in Metastatic HER2 Negative Breast Cancer

Breast Neoplasm | Antineoplastic Agents | Anlotinib

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

Breast Neoplasm Female

China
The First Hospital of Jilin University
First Affiliated Hospital Xi'an Jiaotong University; Qingdao University; First... and other collaborators

Recruiting

Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer (NACVCAC)

Breast Neoplasm Female

China
Wang Ouchen

Recruiting

A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer (neoPICD)

Breast Neoplasm Female

China
Peking Union Medical College

Unknown

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

Breast Neoplasm Female | Mutation | Therapeutics

China
Fudan University
Istituto Superiore di Sanità

Completed

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Breast Cancer | Metastasis, Neoplasm

China
Peking University Cancer Hospital & Institute

Recruiting

Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Breast Neoplasm Female

China
Peking University Cancer Hospital & Institute

Completed

Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer

Breast Neoplasm | Drug Therapy | Polymorphism,Single Nucleotide

China
Fudan University

Completed

Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

Breast Cancer | Metastasis, Neoplasm

China
Fudan University

Recruiting

Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy (FASCINATE-N)

Breast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)

China
Second Affiliated Hospital, School of Medicine,...
Affiliated Hangzhou First People's Hospital, Zhejiang University

Not yet recruiting

Axillary Versus Primary Breast Approach for Second-stage Breast Reconstruction (AvBSR)

Breast Neoplasm Female | Breast Reconstruction | Wound Complication

China
Peking University

Recruiting

To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes

Lymph Node Metastases | Neoplasm, Breast | Neoadjuvant Chemotherapy | Response

China
Fuzhou General Hospital

Not yet recruiting

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer

Breast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor

China
Peking University Cancer Hospital & Institute

Completed

Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (DC-CIK)

Breast Neoplasms | Neoplasm Metastasis

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-sen University; First People's Hospital of Foshan

Unknown

Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients (SYSBTC-001)

Advanced Breast Cancer | Surgery | Breast Neoplasm Female

China
Zhejiang Cancer Hospital

Recruiting

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Breast Neoplasm Female

China
Hubei Cancer Hospital

Enrolling by invitation

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

Breast Neoplasm Female

China
Peking University Cancer Hospital & Institute

Completed

Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (DCCIK)

Breast Neoplasms | Neoplasm Metastasis

China
Handan First Hospital

Active, not recruiting

Circulating Tumor Cells Screen for Breast Cancer (CTCSFBC)

Breast Neoplasm | Neoplastic Cells, Circulating

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Unknown

Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound

Breast Cancer Female

China
Peking University

Recruiting

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

HER2-positive Breast Cancer | Triple-negative Breast Cancer

China
First Affiliated Hospital of Zhejiang University
Shanghai Longfine Biotechnology Co., Ltd.; TopAlliance

Not yet recruiting

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Triple-negative Breast Cancer

China
Fudan University

Recruiting

Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.

Triple-Negative Breast Cancer

China
Fudan University

Recruiting

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

Triple-negative Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Triple Negative Breast Cancer | HER2-positive Breast Cancer

China
Fudan University

Recruiting

A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC.

Triple-Negative Breast Cancer

China
Fudan University

Recruiting

FUSCC Refractory TNBC Umbrella (FUTURE) (FUTURE)

Triple-negative Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer

Triple-negative Breast Cancer

China
Fudan University

Unknown

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Fudan University
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients

Metastatic Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Fudan University

Recruiting

Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Peking Union Medical College Hospital

Recruiting

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer

China
Fudan University

Completed

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC) (TNBC)

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Breast Cancer

China
Fudan University

Unknown

Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer

Breast Cancer

China
RenJi Hospital

Completed

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer (SHPD001)

Inflammatory Breast Cancer | Invasive Ductal Breast Cancer | Tubular Breast Cancer | Mucinous Breast Cancer

China
Fudan University

Recruiting

A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01) (BCTOP-T-N01)

TNBC - Triple-Negative Breast Cancer

China
Beijing 302 Hospital

Recruiting

Study of Eribulin in Combination With Anti-PD-1 Antibody in Patients With Metastatic Triple-Negative Breast Cancer

TNBC - Triple-Negative Breast Cancer

China

Clinical Trials on Unilateral Breast Neoplasms in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations